Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversal of Warfarin-associated Major Hemorrhage: a Multicenter, Retrospective Cohort Study of Fixed-dose Activated (FEIBA VH) Versus Variable-dose Inactivated (Kcentra) Prothrombin Complex Concentrate

NCT02565836 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT02565836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02565836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversal of Warfarin-associated Major Hemorrhage: a Multicenter, Retrospective Cohort Study of Fixed-dose Activated (FEIBA VH) Versus Variable-dose Inactivated (Kcentra) Prothrombin Complex Concentrate
Lead sponsor
Rush University Medical Center
Phase
Observational
Overall status
Completed
Start date
October 31, 2015
Completion date
September 30, 2016
Enrollment
342 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage